Cell wall-mediated neuronal damage in early sepsis.

Area of Science:

• Neuroscience
• Immunology
• Microbiology

Background:

• Sepsis can lead to neuronal dysfunction and damage, a condition known as sepsis-associated neuronal damage (SAND), even in the absence of meningitis.
• SAND has been observed in the hippocampus shortly after the onset of experimental pneumococcal bacteremia.

Purpose of the Study:

• To investigate the mechanisms underlying sepsis-associated neuronal damage (SAND) and explore potential therapeutic interventions.

Main Methods:

• Experimental pneumococcal bacteremia was induced in mice.
• Intravascular challenge with purified bacterial cell wall was performed.
• Mice with genetic modifications (PAFr(-/-), TLR2/Nod2 deficiency, IL-10 overexpression in macrophages) were used to study SAND.
• Treatment with CDP-choline was administered to assess its therapeutic effect.

Main Results:

• Intravascular administration of bacterial cell wall recapitulated SAND in the hippocampus.
• SAND persisted in PAFr(-/-) mice, indicating a role for this pathway.
• Mice lacking cell wall recognition proteins TLR2 and Nod2, and those overexpressing IL-10, showed partially mitigated SAND.
• These findings suggest that bacterial cell walls drive SAND via IL-10-repressible inflammatory pathways.
• CDP-choline treatment ameliorated SAND in the experimental model.

Conclusions:

• Sepsis-associated neuronal damage is driven by bacterial cell wall components through inflammatory mechanisms that are partly regulated by IL-10.
• CDP-choline demonstrates potential as an adjunctive therapy to mitigate neuronal damage and improve outcomes in sepsis.
• Further research into CDP-choline's efficacy could lead to improved survival and reduced organ damage in sepsis patients.